Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 14/20 | 0.61 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.46 |
| ▸ | CSF1R | P07333 | 1/20 | 0.42 |
| ▸ | MAP4K3 | Q8IVH8 | 2/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL488337 | 1.00 | MET (0.61) | METMAP4K4CSF1RMAP4K3JAK2 | |
| SCHEMBL10218093 | 0.91 | MET (0.60) | METMAP4K4MAP4K3 | |
| SCHEMBL30453012 | 0.89 | MET (0.61) | METMAP4K4MAP4K3JAK2 | |
| SCHEMBL488769 | 0.89 | MET (0.61) | METMAP4K4MAP4K3JAK2 | |
| SCHEMBL10218123 | 0.89 | MET (0.61) | METMAP4K4MAP4K3 | |
| SCHEMBL10215375 | 0.87 | MET (0.69) | METMAP4K3JAK2 | |
| SCHEMBL487998 | 0.87 | MET (0.69) | METMAP4K3JAK2 | |
| SCHEMBL30452803 | 0.87 | MET (0.69) | METMAP4K3JAK2 | |
| SCHEMBL10218129 | 0.87 | MET (0.62) | METMAP4K4MAP4K3NPC1RAB9A | |
| SCHEMBL10218208 | 0.86 | MET (0.62) | METMAP4K4MAP4K3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113181362-B | Medicament for preventing and/or treating amyotrophic lateral sclerosis | 国立大学法人京都大学 | 2023-06-13 | — | — | CN | disclosed |